Aklog Lishan 4
4 · CONTRAFECT Corp · Filed May 18, 2022
Insider Transaction Report
Form 4
CONTRAFECT CorpCFRX
Aklog Lishan
Director
Transactions
- Award
Options (Right to Buy)
2022-05-17$3.35/sh+42,000$140,700→ 42,000 totalExercise: $3.35Exp: 2032-05-17→ Common Stock (42,000 underlying)
Footnotes (1)
- [F1]Grant award made under the ContraFect Corporation 2014 Omnibus Incentive Plan. Grant vests over one year, 25% at the end of each quarter following the vesting commencement date.